Taysha Gene Therapies, Inc. (TSHA)
$5.97-1.97%Close
BUYRECOVERY · day 18
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $1.9B
- Avg volume
- 3.1M
- Beta
- 1.19
- P/E (TTM)
- -14.13
- Short % float
- 19.82%
- Days to cover
- 19.0
- SI change
- +3.1%
- 1W
- -3.86%
- 1M
- +8.15%
- 3M
- +8.74%
- YTD
- +13.71%
- vs SPY 1W
- -2.67%
- vs SPY 1M
- +4.83%
- vs SPY 3M
- +6.35%
- vs SPY YTD
- +1.96%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- VTGNBUYVistaGen Therapeutics, Inc.CRISISQ -7$0.24+0.00%
- CELUBUYCelularity Inc.RECOVERYQ -14$0.77-3.75%
- TTRXBUYTurn Therapeutics Inc.RECOVERYQ 33$9.68+2.33%
- INSMBUYInsmed IncorporatedRECOVERYQ 14$123.98-1.42%
- PRFXSELLPRF Technologies Ltd.CRISISQ -19$1.01+1.00%
- ITOCBUYiTonic Holdings Ltd.CRISISQ -21$0.27-6.90%
- ALMRBUYAlamar Biosciences, Inc.Q 83$32.70-4.50%
- XCURSELLExicure, Inc.CRISISQ -13$1.15+0.00%
- XGNBUYExagen Inc.RECOVERYQ 6$7.65-3.41%
- AQSTBUYAquestive Therapeutics, Inc.RECOVERYQ -4$4.80+3.00%
- DCGOSELLDocGo Inc.CRISISQ -29$0.38-11.63%
- SRTSBUYSensus Healthcare, Inc.RECOVERYQ -2$3.49+4.49%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 8
- VALUE
- 6
- GROWTH
- 17
- GARP
- 7
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-33.7%
REV YoY-
ROE-56.2%
EPS YoY-
ROA-31.8%
GROSS84
OP-2792
NET-2728
[VALUATION]
P/E TTM-14.13
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B5.69
P/FCF-
EV/EBITDA-10.15
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E14.34
ALTMAN Z-
CURR RATIO17.76
ND/EBITDA-
BETA1.19
Company news
Loading headlines…